Concepedia

Kelly McCaul

KM

Statistics

Publications

6

Citations

245

H-Index

6

Active since

2000

Affiliations

WinnMed(Current)

Guy's and St Thomas' NHS Foundation Trust

Icahn School of Medicine at Mount Sinai

Hôpital Saint-Louis

Cancer Prevention Institute of California

Kelly McCaul is an author at WinnMed specializing in hematology, medicine, and pharmacotherapy.

Publications per year

2000–2024

6

Publications

6

A Phase 2 Study of Luspatercept in Patients with Myelofibrosis-Associated Anemia

Aaron T. Gerds, Alessandro M. Vannucchi, Francesco Passamonti et al. · Blood · 2019 · 70 citations

, , +4

Treatment of Steroid-Resistant Acute Graft-Versus-Host Disease with Rabbit Antithymocyte Globulin

Kelly McCaul, Thomas J. Nevill, M. J. Barnett et al. · Journal of Hematotherapy & Stem Cell Research · 2000 · 64 citations

, , +14

Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis

Aaron T. Gerds, Claire Harrison, Jean‐Jacques Kiladjian et al. · Blood Advances · 2024 · 43 citations · Full text

, , +9

Duration of Response to Luspatercept in Patients (Pts) Requiring Red Blood Cell (RBC) Transfusions with Myelofibrosis (MF) - Updated Data from the Phase 2 ACE-536-MF-001 Study

Aaron T. Gerds, Alessandro M. Vannucchi, Francesco Passamonti et al. · Blood · 2020 · 30 citations

, , +11

Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia

Bruno C. Medeiros, Kelly McCaul, Suman Kambhampati et al. · Haematologica · 2017 · 21 citations · Full text

, , +15

1–5 of 6